Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Earth Corporation (4985.T)
Tokyo, JP
Earth Corporation, established in 1892 and headquartered in Tokyo, Japan, operates as an international enterprise specializing in the manufacture, marketing, import, and export of a diverse range of products. Serving both Japanese and global markets, its offerings include pharmaceuticals, quasi-drugs, medical instruments, and various household goods. The company is organized into two primary divisions: Household Products Business and General Environment and Sanitation Business. Its extensive product portfolio features pest control solutions such as insecticides and repellents, along with gardening essentials. The household segment encompasses oral care items like mouthwash, denture supplies, and toothpastes, as well as bath salts and air fresheners. Earth Corporation also provides pet care items, specialized chemical agents for communicable disease control, agricultural, forestry, and animal husbandry applications, and raw materials. In addition to products, the company offers hygiene management services. These numerous offerings are marketed under a variety of well-recognized brands, including Earth Red, Saratect, Mondahmin, Bath Roman, Polident, and Sensodyne, among others.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.11% | -1.40% | -3.68% | -8.76% | -7.94% | -8.03% | -6.24% | -10.89% | -30.50% | -6.15% | +65.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+5.9% ★ Q1'26: +7.0% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+51.6% ★ Q1'26: -5.0% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+4.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+4.5% Q1'26: +13.2% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+8.5% ★ Q1'26: +20.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-0.6% ★ Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.60× ★ Q1'26: 0.72× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
159.74B
est: 160.00B (-0.2%)
|
168.51B
est: 167.40B (+0.7%)
|
179.74B
est: 181.70B (-1.1%)
|
181.10B
est: 187.20B (-3.3%)
|
189.53B
est: 188.50B (+0.5%)
|
196.05B
est: 194.72B (+0.7%)
|
203.79B
est: 201.24B (+1.3%)
|
152.34B
est: 153.11B (-0.5%)
|
158.34B
est: 165.11B (-4.1%)
|
169.28B
est: 167.33B (+1.2%)
|
179.18B
est: 177.49B (+1.0%)
|
186.90B
185.40B – 188.50B
+5.3% YoY
|
192.83B
191.50B – 195.20B
+3.2% YoY
|
198.63B
198.63B – 198.63B
+3.0% YoY
|
205.00B
203.47B – 207.14B
+3.2% YoY
|
211.05B
209.48B – 213.25B
+3.0% YoY
|
| EBITDA |
7.90B
est: 11.49B (-31.3%)
|
9.73B
est: 12.02B (-19.1%)
|
9.75B
est: 13.04B (-25.3%)
|
6.89B
est: 13.44B (-48.8%)
|
9.85B
est: 13.53B (-27.2%)
|
17.19B
est: 13.98B (+23.0%)
|
16.04B
est: 14.45B (+11.0%)
|
11.72B
est: 10.99B (+6.6%)
|
10.61B
est: 11.86B (-10.5%)
|
11.00B
est: 12.01B (-8.5%)
|
12.80B
est: 12.74B (+0.4%)
|
13.42B
13.31B – 13.53B
+5.3% YoY
|
13.85B
13.75B – 14.02B
+3.2% YoY
|
14.26B
14.26B – 14.26B
+3.0% YoY
|
14.72B
14.61B – 14.87B
+3.2% YoY
|
15.15B
15.04B – 15.31B
+3.0% YoY
|
| EBIT |
3.99B
est: 7.08B (-43.7%)
|
5.54B
est: 7.41B (-25.2%)
|
4.46B
est: 8.04B (-44.6%)
|
1.04B
est: 8.29B (-87.5%)
|
3.92B
est: 8.34B (-53.0%)
|
11.42B
est: 8.62B (+32.5%)
|
10.67B
est: 8.91B (+19.8%)
|
7.44B
est: 6.78B (+9.7%)
|
6.37B
est: 7.41B (-14.0%)
|
6.43B
est: 7.51B (-14.4%)
|
8.05B
est: 7.96B (+1.1%)
|
8.38B
8.32B – 8.45B
+5.3% YoY
|
8.65B
8.59B – 8.75B
+3.2% YoY
|
8.91B
8.91B – 8.91B
+3.0% YoY
|
9.19B
9.13B – 9.29B
+3.2% YoY
|
9.47B
9.40B – 9.56B
+3.0% YoY
|
| Net Income |
1.17B
est: 2.03B (-42.7%)
|
3.36B
est: 3.36B (+0.1%)
|
2.21B
est: 2.17B (+1.4%)
|
-143.00M
est: 3.50B (-104.1%)
|
1.25B
est: 1.26B (-0.7%)
|
3.55B
est: 5.31B (-33.2%)
|
7.14B
est: 7.02B (+1.8%)
|
5.30B
est: 6.23B (-14.9%)
|
4.10B
est: 4.65B (-11.8%)
|
3.48B
est: 3.48B (-0.2%)
|
5.24B
est: 5.24B (+0.0%)
|
6.15B
5.22B – 6.73B
+17.3% YoY
|
6.49B
5.32B – 7.19B
+5.5% YoY
|
6.96B
5.72B – 7.67B
+7.3% YoY
|
8.11B
8.03B – 8.22B
+16.6% YoY
|
8.66B
8.58B – 8.78B
+6.8% YoY
|
| SGA |
49.72B
est: 35.17B (+41.3%)
|
52.78B
est: 36.80B (+43.4%)
|
57.73B
est: 39.94B (+44.5%)
|
59.79B
est: 41.15B (+45.3%)
|
60.15B
est: 41.44B (+45.1%)
|
61.30B
est: 42.81B (+43.2%)
|
65.38B
est: 44.24B (+47.8%)
|
49.91B
est: 33.66B (+48.3%)
|
52.11B
est: 54.62B (-4.6%)
|
56.96B
est: 55.36B (+2.9%)
|
60.93B
est: 58.72B (+3.8%)
|
61.83B
61.33B – 62.36B
+5.3% YoY
|
63.79B
63.35B – 64.57B
+3.2% YoY
|
65.71B
65.71B – 65.71B
+3.0% YoY
|
67.82B
67.31B – 68.52B
+3.2% YoY
|
69.82B
69.30B – 70.55B
+3.0% YoY
|
| EPS |
57.69
est: 92.60 (-37.7%)
|
166.58
est: 153.00 (+8.9%)
|
109.19
est: 99.00 (+10.3%)
|
-7.03
est: 159.40 (-104.4%)
|
61.80
est: 57.40 (+7.7%)
|
170.64
est: 241.85 (-29.4%)
|
323.72
est: 319.60 (+1.3%)
|
240.44
est: 285.15 (-15.7%)
|
185.55
est: 212.66 (-12.7%)
|
158.26
est: 159.27 (-0.6%)
|
239.99
est: 236.85 (+1.3%)
|
281.27
239.21 – 308.50
+18.8% YoY
|
296.86
243.79 – 329.60
+5.5% YoY
|
318.49
262.08 – 351.50
+7.3% YoY
|
371.70
368.09 – 376.75
+16.7% YoY
|
396.80
392.95 – 402.19
+6.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.06% | 247.9K | 0.58% |
| 2 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.04% | 211.3K | 0.58% |
| 3 | State Street SPDR S&P International Small Cap ETF GWX | 0.03% | 273.0K | 0.40% |
| 4 | iShares MSCI Japan Small-Cap ETF SCJ | 0.03% | 69.8K | 0.50% |
| 5 | Schwab Fundamental International Small Company Index ETF FNDC | 0.02% | 637.5K | 0.39% |
| 6 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 990.1K | 0.06% |
| 7 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 46.4K | 0.30% |
| 8 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.01% | 27.2K | 0.83% |
| 9 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.01% | 1.64M | 0.40% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.58M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Katsunori Kawabata | President, Chief Executive Officer & Representative Director | 132M | male |
| Hisaaki Karataki | Senior Executive Officer of Administrative Division | — | male |
| Isao Goji | Senior Executive Officer, Director General & Corporate Planning Headquarters | — | — |
| Sakamoto | Manager of Finance Management Department | — | — |
| Takeshi Shakata | Executive VP, Director General of Sales & Director | — | male |
| Yoshiyuki Furuya | Senior Executive VP & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4985.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
